Celgene snags new approval for Otezla

Celgene announced that the U.S. FDA has approved Otezla for the treatment of adult patients with oral ulcers associated with Beh çet’s Disease.

Source: PharmaManufacturing.com - July 22, 2019 Category: Pharmaceuticals Source Type: news